APA (7th ed.) Citation

Hjortebjerg, R., Thomsen, K. L., Agnholt, J., & Frystyk, J. (2019). The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: Potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis. BMC gastroenterology, 19(1), 83-11. https://doi.org/10.1186/s12876-019-1000-6

Chicago Style (17th ed.) Citation

Hjortebjerg, Rikke, Karen L. Thomsen, Jørgen Agnholt, and Jan Frystyk. "The IGF System in Patients with Inflammatory Bowel Disease Treated with Prednisolone or Infliximab: Potential Role of the Stanniocalcin-2 / PAPP-A / IGFBP-4 Axis." BMC Gastroenterology 19, no. 1 (2019): 83-11. https://doi.org/10.1186/s12876-019-1000-6.

MLA (9th ed.) Citation

Hjortebjerg, Rikke, et al. "The IGF System in Patients with Inflammatory Bowel Disease Treated with Prednisolone or Infliximab: Potential Role of the Stanniocalcin-2 / PAPP-A / IGFBP-4 Axis." BMC Gastroenterology, vol. 19, no. 1, 2019, pp. 83-11, https://doi.org/10.1186/s12876-019-1000-6.